Mir-145
Mir-145 is a microRNA that plays a significant role in the regulation of gene expression in various cellular processes, including cell differentiation, proliferation, and apoptosis. It is encoded by the MIR145 gene and is involved in the complex network of RNA interference (RNAi), acting as a post-transcriptional regulator of gene expression by binding to the 3' untranslated regions (3' UTRs) of target messenger RNA (mRNA) molecules, leading to their degradation or inhibition of translation.
Function[edit | edit source]
Mir-145 is highly conserved across different species, indicating its crucial role in cellular functions. It has been identified as a key regulator in the differentiation of smooth muscle cells, playing a significant role in vascular disease. Moreover, mir-145 is involved in the regulation of several oncogenes and has been implicated in the pathogenesis of various cancers, acting as a tumor suppressor in some contexts. Its expression levels are often downregulated in cancerous tissues compared to normal tissues, suggesting its potential role in tumor suppression and as a biomarker for cancer diagnosis and prognosis.
Clinical Significance[edit | edit source]
The dysregulation of mir-145 has been associated with a variety of diseases, particularly cancers such as colorectal cancer, breast cancer, and prostate cancer. Studies have shown that restoring mir-145 expression in cancer cells can inhibit tumor growth, metastasis, and induce apoptosis, highlighting its potential as a therapeutic target. In addition to cancer, mir-145 has been linked to cardiovascular diseases, contributing to vascular remodeling and atherosclerosis through its effects on smooth muscle cell phenotype and function.
Research and Therapeutic Potential[edit | edit source]
Given its role in cancer and other diseases, mir-145 has been the subject of extensive research aimed at understanding its molecular mechanisms and therapeutic potential. Strategies to modulate mir-145 levels, including the use of miRNA mimics and antagomirs, are being explored for the treatment of cancer and cardiovascular diseases. The development of targeted delivery systems to restore or inhibit mir-145 function in specific tissues presents a promising avenue for future therapies.
See Also[edit | edit source]
 | This oncology article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
